You searched for side effects - Page 20 of 311 - Medivizor
Navigation Menu

Searching for patients with hypertension after pregnancy to test the effects of non-steroidal anti-inflammatory drugs

Posted by on May 23, 2017 in Hypertension | 0 comments

In a nutshell The aim of this clinical trial is to test the effects of non-steroidal anti-inflammatory drugs on blood pressure in women with mild and severe hypertension after pregnancy. For patients with mild hypertension, the main outcome to be investigated is change in blood pressure throughout the study. For patients with severe hypertension, the...

Read More

Gestational diabetes: The effects of lifestyle interventions for mother and baby

Gestational diabetes: The effects of lifestyle interventions for mother and baby

Posted by on May 16, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study analyzed the results of 15 separate studies to examine the effects of lifestyle interventions for gestational diabetes mellitus (GDM). Authors reported on a number of benefits for the mother and the baby following lifestyle interventions. Some background When a woman without diabetes develops high blood glucose levels...

Read More

Long-term effects of stereotactic ablative radiotherapy for patients with NSCLC

Posted by on May 2, 2017 in Lung cancer | 0 comments

In a nutshell The authors examined the long-term effects of stereotactic ablative radiotherapy (SABR) in treating patients with stage 1 non-small-cell lung cancer (NSCLC). They concluded that SABR is both safe and effective in the long-term. Some background SABR is a type of radiation used to treat inoperable early stage NSCLC. Studies have shown...

Read More

Late effects of Hodgkin lymphoma in teenager and young adult survivors

Posted by on Apr 14, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the amount of late complications that affect teenage and young adult Hodgkin lymphoma survivors. The authors concluded that these patients had higher risks of developing other cancers and getting sick compared to the general population. Some background Hodgkin lymphoma (HL) is the most common cancer among...

Read More

Comparing the effects of combined PI3K inhibitor/endocrine therapy versus endocrine therapy alone in ER-positive breast cancer

Posted by on Apr 3, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether the addition of the PI3K inhibitor pictilisib (Stemolecule GDC-0941) can increase the anti-tumor effects of anastrozole (Arimidex) in patients with estrogen receptor-positive (ER-positive) primary breast cancer (BC). Combined treatment with pictilisib (PIC)...

Read More

The beneficial effects of trastuzumab on locoregional control in HER2-positive breast cancer patients.

Posted by on Mar 27, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of trastuzumab (Herceptin) on the locoregional control (management in the area in which it arose) of patients with HER2-positive breast cancer (HER2+BC) following radiotherapy (RT). Trastuzumab administered alongside RT was found to be associated with a significantly reduced rate of locoregional...

Read More

Late effects of treatment in Hodgkin lymphoma

Posted by on Dec 16, 2016 in Hodgkin's lymphoma | 0 comments

In a nutshell This article summarized some of the possible late effects of Hodgkin lymphoma treatment. Some background The standard treatment options for Hodgkin lymphoma are radiation and chemotherapy. These treatments have led to very high remission rates (no sign of disease) in many patients. Radiation and chemotherapy have also been associated...

Read More